相似文献
1
Comparison of dissolution profiles for sustained release resinates of BCS class I drugs using USP apparatus 2 and 4: a technical note.
AAPS PharmSciTech. 2008;9(3):769-73. doi: 10.1208/s12249-008-9110-4. Epub 2008 Jun 18.
2
Is the full potential of the biopharmaceutics classification system reached?
Eur J Pharm Sci. 2014 Jun 16;57:224-31. doi: 10.1016/j.ejps.2013.09.010. Epub 2013 Sep 25.
3
Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples.
Int J Pharm. 2008 Sep 1;361(1-2):70-7. doi: 10.1016/j.ijpharm.2008.05.021. Epub 2008 May 28.
4
A non-binary biopharmaceutical classification of drugs: the ABΓ system.
Int J Pharm. 2014 Apr 10;464(1-2):85-90. doi: 10.1016/j.ijpharm.2014.01.022. Epub 2014 Jan 21.
5
Very rapid dissolution is not needed to guarantee bioequivalence for biopharmaceutics classification system (BCS) I drugs.
J Pharm Sci. 2010 Feb;99(2):621-5. doi: 10.1002/jps.21879.
6
Ion Exchange Resins Transforming Drug Delivery Systems.
Curr Drug Deliv. 2010 Jul;7(3):252-62.
7
A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
J Pharm Sci. 2013 Sep;102(9):3136-44. doi: 10.1002/jps.23515. Epub 2013 Apr 11.
8
Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver.
J Pharm Sci. 2018 Jun;107(6):1478-1488. doi: 10.1016/j.xphs.2018.01.025. Epub 2018 Feb 6.
9
The developability classification system: application of biopharmaceutics concepts to formulation development.
J Pharm Sci. 2010 Dec;99(12):4940-54. doi: 10.1002/jps.22217.
10
Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.
Pharm Res. 2012 Nov;29(11):3188-98. doi: 10.1007/s11095-012-0815-4. Epub 2012 Jul 4.
引用本文的文献
1
Discriminative Dissolution Method Using the Open-Loop Configuration of the USP IV Apparatus to Compare Dissolution Profiles of Metoprolol Tartrate Immediate-Release Tablets: Use of Kinetic Parameters.
Pharmaceutics. 2023 Aug 24;15(9):2191. doi: 10.3390/pharmaceutics15092191.
2
Bio-Hybrid Hydrogels Incorporated into a System of Salicylic Acid-pH/Thermosensitive Nanocarriers Intended for Cutaneous Wound-Healing Processes.
Pharmaceutics. 2022 Apr 1;14(4):773. doi: 10.3390/pharmaceutics14040773.
3
Comparative Study of Antibacterial Effects of Titanium Dioxide Nanoparticles Alone and in Combination with Antibiotics on MDR Strains.
Int J Nanomedicine. 2020 May 14;15:3393-3404. doi: 10.2147/IJN.S246310. eCollection 2020.
4
The load and release characteristics on a strong cationic ion-exchange fiber: kinetics, thermodynamics, and influences.
Drug Des Devel Ther. 2014 Jul 16;8:945-55. doi: 10.2147/DDDT.S64604. eCollection 2014.
本文引用的文献
1
Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Int J Pharm. 2007 Jun 7;337(1-2):246-53. doi: 10.1016/j.ijpharm.2007.01.026. Epub 2007 Jan 20.
2
Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds.
Eur J Pharm Biopharm. 2005 Aug;60(3):413-7. doi: 10.1016/j.ejpb.2005.03.002.
3
The delayed dissolution of paracetamol products in the canine fed stomach can be predicted in vitro but it does not affect the onset of plasma levels.
Int J Pharm. 2005 May 30;296(1-2):87-93. doi: 10.1016/j.ijpharm.2005.02.028. Epub 2005 Apr 7.
4
In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media.
Eur J Pharm Sci. 2005 Mar;24(4):305-13. doi: 10.1016/j.ejps.2004.11.007. Epub 2005 Jan 6.
5
In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis.
Eur J Pharm Sci. 2005 Jan;24(1):115-22. doi: 10.1016/j.ejps.2004.10.003.
6
In vitro and in vivo evaluation of a matrix-in-cylinder system for sustained drug delivery.
J Control Release. 2004 Apr 28;96(2):261-71. doi: 10.1016/j.jconrel.2004.01.023.
7
Ion-exchange resins: carrying drug delivery forward.
Drug Discov Today. 2001 Sep 1;6(17):905-914. doi: 10.1016/s1359-6446(01)01922-5.
8
Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration.
Pharm Res. 2001 Mar;18(3):380-8. doi: 10.1023/a:1011071401306.
9
Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans.
Eur J Pharm Sci. 2001 Jan;12(3):239-50. doi: 10.1016/s0928-0987(00)00138-x.
10
Robustness testing, using experimental design, of a flow-through dissolution method for a product where the actives have markedly differing solubility properties.
Int J Pharm. 2000 Sep 25;206(1-2):55-61. doi: 10.1016/s0378-5173(00)00509-3.
Zotero 插件